Abstract

Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2

Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas C

Issue: Jul/Aug 2014 - Volume 18, Number 4

Page(s): 305-310

Download in electronic PDF format for $75
  • Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Page 1
  • Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Page 2
  • Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Page 3
  • Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Page 4
  • Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Page 5
  • Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Page 6

Abstract

Cases of contaminated nonsterile products have been reported in increasing numbers. Often, these contaminated products are associated with the presence of objectionable microorganisms. The major contaminants of nonsterile pharmaceutical products and ingredients are bacteria, yeasts, and molds. The combination of parts 1 and 2 of this series of articles provides a thorough examination of microbiological quality testing for nonsterile products.

Related Keywords

  • nonsterile compounding
  • microbial limit testing
  • contaminants
  • contamination
  • United States Pharmacopeia Chapter <61> Microbial Examination of Non-Sterile Products
  • United States Pharmacopeia Chapter <62> Tests for Specified Microorganisms
  • USP
  • bacteria
  • yeast
  • molds
  • fungi
  • microbiological acceptance criteria
  • dosage forms
  • specified micro-organisms
  • testing media
  • testing medium
  • test frequency
  • stability testing
  • objectionable foodborne organisms
  • U.S. Food and Drug Administration
  • FDA
  • water activity

Related Categories

  • LEGAL
  • QUALITY CONTROL
  • UNITED STATES PHARMACOPEIA CONVENTIONS
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2014
Pg. 305-310
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas C
May/Jun 2014
Pg. 213-221
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1
Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas
Mar/Apr 2021
Pg. 115-124
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 356
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 92
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Author(s): Allen Loyd V Jr
May/Jun 2008
Pg. 216-229
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Author(s): Kastango Eric S
Sep/Oct 2007
Pg. 400-403
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Author(s): Kupiec Thomas C
Jan/Feb 2012
Pg. 64-68
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 146-150
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Author(s): Allen Loyd V Jr
Jul/Aug 2019
Pg. 299-303
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 180
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Author(s): Allen Loyd V Jr
May/Jun 2008
Pg. 252-257
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2011
Pg. 488-496
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 408-414
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2
Author(s): Allen Loyd V Jr
Sep/Oct 2007
Pg. 404-410
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Author(s): Allen Loyd V Jr, Okeke Claudia C
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
May/Jun 2017
Pg. 193-203
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Author(s): Mixon William, Roth Abby
Jan/Feb 2006
Pg. 36-39
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations
Author(s): Dawson Michael F
Mar/Apr 2014
Pg. 123-130
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Author(s): Vu Nicole, Nguyen Devin, Kupiec Thomas C